Aquinox Pharmaceuticals Phase 2 KINSHIP Trial With AQX-1125 in Patients With Atopic Dermatitis Fails to Demonstrate Efficacy
November 03, 2015 at 04:21 AM EST
Aquinox Pharmaceuticals,Inc. ("Aquinox") (Nasdaq: AQXP) announced Monday, its Phase 2 KINSHIP clinical trial failed to ...